Myers Industries Inc (MYE) · Oct 29, 2026 · Earnings
Miss — Diluted EPS $0.13 vs ~$0.45 published consensus; revenue $171.3M vs ~$163.8M
Myers Industries earnings beat revenue expectations, but resin costs and product mix cut margins; Q4 recovery now carries the story.
Myers Industries is in the middle of a portfolio-and-operations transformation: exiting low-margin work, concentrating on engineered products, and leaning on Infrastructure and Food & Beverage growth platforms. That strategy is producing sales growth, but the quarter shows profitability still vulnerable to input-cost and product-mix swings. The company’s stated transformation priorities include portfolio refinement, organic growth in high-return applications, disciplined cost management, and stronger cash flow generation.
Revenue was better than the market expected, but the quality of that growth was uneven. Net sales rose 8.1% to $171.3 million, ahead of the published ~$163.8 million consensus, with Infrastructure up 38% and Food & Beverage up 12%; Industrial, Consumer, and Vehicle sales were flat. The company said sales increased 10.4% excluding the low-margin products exited after two facilities were idled.
| Q3 2026 | Q3 2025 | Consensus | |
|---|---|---|---|
| Net sales (Financial Summary) | $171.3M (+8.1%) | $158.5M | ~$163.8M |
| Diluted EPS, continuing operations (Financial Summary) | $0.13 (-23.5%) | $0.17 | ~$0.45* |
| Adjusted EPS, continuing operations (Financial Summary) | $0.32 (+3.2%) | $0.31 | |
| Gross margin (Financial Summary) | 27.3% (-380 bps) | 31.1% | |
| Adjusted EBITDA margin (Financial Summary) | 15.5% (-280 bps) | 18.3% |
*The published EPS estimate does not clearly identify a GAAP versus adjusted basis, so the EPS comparison is directional rather than perfectly like-for-like.
Margins, not demand, were the quarter’s main problem. Gross profit fell 5.0% and adjusted EBITDA declined 8.2% despite higher revenue, as a resin-cost spike, unfavorable mix, and unplanned maintenance overwhelmed pricing and volume benefits. 〔0〕
The recovery case is now concentrated in Q4 execution. Management says resin costs have stabilized and pricing actions remain in place, forecasting significant sequential margin improvement in the fourth quarter. That is a credible bridge for a rebound, but it is forward-looking rather than demonstrated in this quarter. 〔1〕
The balance sheet gives the transformation room to continue. Operating cash flow was $17.4 million, free cash flow was $11.5 million, and net leverage improved to 1.86x from 1.94x in the second quarter. The completed Myers Tire Supply sale also simplifies the portfolio, though that strategic direction was already known rather than a fresh surprise. 〔2〕
Bottom line: This was a mixed quarter: demand and portfolio focus held up better than expected, but input-cost pressure caused a clear earnings miss. The business story now depends on whether the promised Q4 margin recovery actually appears, not on further evidence of revenue growth.
Q4 results and evidence of margin recovery
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!